News

Research transfer: CeNS spin-off receives multi-million euro EU grant

20 Mar 2025

CeNS member Olivia Merkel researches nanocarriers for the targeted delivery of drugs to their site of action. Now the company she co-founded, RNhale, has been awarded a lucrative EU grant to bring a new anti-asthma therapy to clinical readiness.

The company name describes the envisioned product in a nutshell: RNhale – that is, RNA therapeutics to inhale. Now the young Munich-based company has been awarded a Transition grant of 2.5 million euros by the European Innovation Council (EIC) to bring such a novel anti-asthma drug to clinical practice.

Research transfer: CeNS spin-off receives multi-million euro EU grant

What are you looking for?